首页> 外文OA文献 >ACTR-13. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFICATION RATES OBSERVED IN SCREENING PATIENTS FOR RANDOMIZED CLINICAL TRIALS IN GLIOBLASTOMA

【2h】

ACTR-13. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFICATION RATES OBSERVED IN SCREENING PATIENTS FOR RANDOMIZED CLINICAL TRIALS IN GLIOBLASTOMA

机译：ACTR-13。表皮生长因子受体（EGFR）在筛查患者胶质母细胞瘤中随机临床试验中观察到的扩增率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Martin van den Bent; Lisa A Roberts-Rapp; Peter J Ansell; James Lee; Jim Looman; Earle Bain; Christopher Ocampo; Kyle D Holen; Erica J Gomez; Andrew B Lassman;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma [J] . Andrew B. Lassman, Kenneth D. Aldape, Peter J. Ansell, Journal of neuro-oncology. . 2019,第1期

机译：在筛选胶质母细胞瘤中随机试验中观察到表皮生长因子受体（EGFR）扩增率
2. The Role of Smoking Status on the Progression-Free Survival of Non-Small Cell Lung Cancer Patients Harboring Activating Epidermal Growth Factor Receptor (EGFR) Mutations Receiving First-Line EGFR Tyrosine Kinase Inhibitor Versus Platinum Doublet Chemotherapy: A Meta-Analysis of Prospective Randomized Trials [J] . Hasegawa Yoshikazu, Ando Masahiko, Maemondo Makoto, The oncologist . 2015,第3期

机译：吸烟状态在非活化小细胞肺癌患者无进展生存中的作用，该患者具有接受一线EGFR酪氨酸激酶抑制剂与铂类双重治疗的活化表皮生长因子受体（EGFR）突变：前瞻性随机试验的荟萃分析。
3. The Role of Smoking Status on the Progression-Free Survival of Non-Small Cell Lung Cancer Patients Harboring Activating Epidermal Growth Factor Receptor (EGFR) Mutations Receiving First-Line EGFR Tyrosine Kinase Inhibitor Versus Platinum Doublet Chemotherapy: A Meta-Analysis of Prospective Randomized Trials [J] . Yoshikazu Hasegawa, Masahiko Ando, Makoto Maemondo, The oncologist . 2015,第3期

机译：吸烟状态对非小细胞肺癌患者无进展生存的作用
4. Effect of preoperative cancer treatment on epidermal growth factor receptor (EGFR) receptor expression level in ABY-029 guided sarcoma surgery [C] . Xiaochun Xu, Kimberley S Samkoe, Eric R. Henderson Society of Photo-Optical Instrumentation Engineers;Conference on Molecular-Guided Surgery: Molecules, Devices, and Applications . 2020

机译：术前癌症治疗对ABY-029导向肉瘤手术中表皮生长因子受体（EGFR）受体表达水平的影响
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. ACTR-13. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFICATION RATES OBSERVED IN SCREENING PATIENTS FOR RANDOMIZED CLINICAL TRIALS IN GLIOBLASTOMA [O] . Martin van den Bent, Lisa A Roberts-Rapp, Peter J Ansell, 2017

机译：ACTR-13。在胶质母细胞瘤随机临床试验筛查患者中观察到的表皮生长因子受体（EGFR）扩增率
7. PCN2 A Meta-Analysis of Randomized Clinical Trials (RCTS) on Epidermal Growth Factor Receptor -Tyrosine Kinase Inhibitors (EGFR-TKIS) for Advanced Non-Small Cell Lung Cancer (NSCLC) [O] . Zhang T., Xu J., Ma J., 2014

机译：PCN2对晚期非小细胞肺癌（NSCLC）的表皮生长因子受体-酪氨酸激酶抑制剂（EGFR-TKIS）的随机临床试验（RCTS）的荟萃分析

ACTR-13. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFICATION RATES OBSERVED IN SCREENING PATIENTS FOR RANDOMIZED CLINICAL TRIALS IN GLIOBLASTOMA

著录项

相似文献

相关主题

期刊订阅